Question 1

How does montelukast sodium compare to my current asthma treatments?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Investigation of Intravenous (IV) Administration of an Approved Drug (MK-0476, Montelukast Sodium) for Acute Asthma (MK-0476-288) clinical trial (NCT00092989). Contact the study team or your healthcare provider for specific answers.

Question 2

What are the potential side effects of receiving montelukast through an IV?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Investigation of Intravenous (IV) Administration of an Approved Drug (MK-0476, Montelukast Sodium) for Acute Asthma (MK-0476-288) clinical trial (NCT00092989). Contact the study team or your healthcare provider for specific answers.

Question 3

How will this trial impact my asthma management plan?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Investigation of Intravenous (IV) Administration of an Approved Drug (MK-0476, Montelukast Sodium) for Acute Asthma (MK-0476-288) clinical trial (NCT00092989). Contact the study team or your healthcare provider for specific answers.

Question 4

What should I expect during the treatment process in the emergency department?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Investigation of Intravenous (IV) Administration of an Approved Drug (MK-0476, Montelukast Sodium) for Acute Asthma (MK-0476-288) clinical trial (NCT00092989). Contact the study team or your healthcare provider for specific answers.

Question 5

Are there any risks associated with participating in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Investigation of Intravenous (IV) Administration of an Approved Drug (MK-0476, Montelukast Sodium) for Acute Asthma (MK-0476-288) clinical trial (NCT00092989). Contact the study team or your healthcare provider for specific answers.

Question 6

How will my progress be monitored during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Investigation of Intravenous (IV) Administration of an Approved Drug (MK-0476, Montelukast Sodium) for Acute Asthma (MK-0476-288) clinical trial (NCT00092989). Contact the study team or your healthcare provider for specific answers.

What this study is about